NCT05448378已完成不适用
Evaluation of the Effects of D-chiro-inositol in Female Healthy Volunteer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 10
- 试验地点
- 4
- 主要终点
- Testosterone
研究概览
简要总结
Healthy women will take tablets containing 600 mg D-chiro-inositol twice per day for one month. We will evaluate metabolic and hormonal.parameters, as insulienmia, glycemia, estradiol, testosterone.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Good state of health;
- •Regular menstrual cycle.
排除标准
- •pregnancy;
- •delivery in the previous 6 months;
- •currently breastfeeding;
- •menopause;
- •alcohol or drug abuse;
- •insulin resistance defined as HOMA-IR index greater than or equal to 2.5;
- •other medical morbidities, such as hypertension, PCOS, or diabetes;
- •oligomenorrhea or amenorrhea;
- •current treatment with corticosteroids or hormones (oral contraceptives, estrogensic, progestogensin);
- •use of GnRH analogues, SERMs, or SPRMs within the previous 6 months.
结局指标
主要结局
Testosterone
时间窗: 30 days
Serum values of testosterone
次要结局
- FSH(30 days)
- Estradiol(30 days)
- Glycemia(30 days)
- Insulinemia(30 days)
- LH(30 days)
- BMI(30 days)
- HOMA-IR index(30 days)
- DHEAS(30 days)
- Asprosin(30 days)
研究者
研究点 (4)
Loading locations...
相似试验
已完成
不适用
D-chiro-inositol and Endometrial ThicknessEndometrial DiseasesNCT05283642Lo.Li.Pharma s.r.l13
招募中
2 期
Evaluation the efficacy of D-Chiro-Inositol in endometriosisEndometriosisIRCT20230111057113N1Shahid Beheshti University of Medical Sciences60
已完成
不适用
D-chiro-inositol Increases Androgens and Reduces Estrogens in Human SerumLow Serum Testosterone Levels in ManNCT04615767AGUNCO Obstetrics and Gynecology Centre10
已完成
不适用
Efficacy and Safety of D-chiro-inositol in Obese PatientsInsulin ResistanceNCT05348941Lo.Li.Pharma s.r.l44
已完成
3 期
D-chiro-Inositol in Overweight Type 1 Diabetes PatientsType 1 DiabetesNCT02730949Campus Bio-Medico University26